Please assess the completion status of the following clinical trial:

Trial Title: Phenylephrine Versus Ephedrine in Pre-eclampsia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* English speaking~* Age ≥18 yrs~* Pre-eclampsia (mild, or severe)~* Non-laboring women~* CD under spinal anesthesia~Exclusion Criteria:~* Height \< 5'0~* Allergy to phenylephrine or ephedrine, or any other standardized medication~* Severe Cardiac disease in pregnancy with marked functional limitations (NYHA Class III and IV)~* Patients on Monoamine Oxidase Inhibitors or Tricyclic Antidepressants~* History of recent amphetamine or cocaine use.~* Subject enrollment in another study involving a study medication within 30 days of CD~* Any other physical or psychiatric condition which may impair their ability to cooperate with study data collection

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Phenylephrine (Type: ACTIVE_COMPARATOR): Phenylephrine for maintaining blood pressure within 10 % of baseline
- Ephedrine (Type: ACTIVE_COMPARATOR): Ephedrine for maintaining blood pressure within 10 % of baseline

Based on this trial design, predict the completion outcome and termination type (if applicable).